cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
about
Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeuticsLFA-1 on leukemic cells as a target for therapy or drug delivery.Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response.Delivery of a transforming growth factor β-1 plasmid to mesenchymal stem cells via cationized Pleurotus eryngii polysaccharide nanoparticlesDevelopment and Characterization of FLT3-Specific Curcumin-Loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-Overexpressing Leukemic Cells.Sophora flavescens protects against mycobacterial Trehalose Dimycolate-induced lung granuloma by inhibiting inflammation and infiltration of macrophages.
P2860
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@en
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@nl
type
label
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@en
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@nl
prefLabel
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@en
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@nl
P2093
P2860
P356
P1476
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
@en
P2093
Chuda Chittasupho
Cory Berkland
Jeffrey P Krise
Prakash Manikwar
Teruna J Siahaan
P2860
P304
P356
10.1021/MP900185U
P407
P577
2010-02-01T00:00:00Z